Long-term safety and tolerability after conversion from mycophenolate mofetil (MMF) to enteric-coated mycophenolate sodium (EC-MPS, myfortic) in stable maintenance renal transplant recipients

被引：0
|
作者：
Chapman, J [1 ]
机构：
[1] Westmead Hosp, Westmead, NSW 2145, Australia
来源：
IMMUNOLOGY AND CELL BIOLOGY | 2006年 / 84卷 / 03期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：A7 / A7
页数：1
相关论文
共 50 条
  • [1] LONG-TERM SAFETY AND TOLERABILITY AFTER CONVERSION FROM MYCOPHNOLATE MOFETIL (MMF) TO ENTERIC-COATED MYCOPHENOLATE SODIUM (EC-MPS, MYFORTIC) IN STABLE MAINTENANCE RENAL TRANSPLANT RECIPIENTS
    Walker, Rowan
    [J]. NEPHROLOGY, 2005, 10 : A207 - A207
  • [2] Long-term safety and efficacy after conversion of maintenance renal transplant recipients from mycophenolate mofetil (MMF) to enteric-coated mycophenolate sodium (EC-MPA, myfortic®)
    Budde, K.
    Knoll, G.
    Curtis, J.
    Chan, L.
    Pohanka, E.
    Gentil, M.
    Seifu, Y.
    Marrast, A. -C.
    Neumayer, H. -H.
    [J]. CLINICAL NEPHROLOGY, 2006, 66 (02) : 103 - 111
  • [3] CONVERSION OF MYCOPHENOLATE MOFETIL (MMF) TO ENTERIC COATED MYCOPHENOLATE SODIUM (EC-MPS) IN PEDIATRIC RENAL TRANSPLANT RECIPIENTS
    Matsuda-Abedini, Mina
    Kiang, Tony K. L.
    Ensom, Mary H. H.
    [J]. PEDIATRIC TRANSPLANTATION, 2011, 15 : 131 - 131
  • [4] LONG-TERM SAFETY OF ENTERIC-COATED MYCOPHENOLATE SODIUM (EC-MPS) IN RENAL TRANSPLANT RECIPIENTS
    Neumayer, Hans H.
    [J]. NEPHROLOGY, 2005, 10 : A213 - A213
  • [5] Enteric-coated mycophenolate sodium (EC-MPS) and mycophenolate mofetil (MMF), it is better to have the choice
    Budde, K
    Salvadori, M
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (05) : 1165 - 1166
  • [6] Interest of conversion from mycophenolate mofetil (MMF) to enteric coated mycophenolate sodium EC-MPS in stable renal transplanted children.
    Meneses, Rejane de Paula
    Kotsifas, Cecilia Hallush
    Olandoski, Karen Previdi
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 367 - 367
  • [7] Conversion of Mycophenolate Mofetil (MMF) to Enteric-Coated Mycophenolate Sodium (EC-MPS) Ameliorates GI Symptoms in Liver Transplant Patients.
    de Vera, Michael E.
    Hope, Laurie
    Yelochan, Barbara
    Durant, Stephanie
    Lopez-Solis, Roberto
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 531 - 531
  • [8] Long-term administration of enteric-coated mycophenolate sodium (EC-MPS; myfortic®) is safe in kidney transplant patients
    Salvadori, M.
    Holzer, H.
    Civati, G.
    Sollinger, H.
    Lien, B.
    Tomlanovich, S.
    Bertoni, E.
    Seifu, Y.
    Marrast, A. -C.
    [J]. CLINICAL NEPHROLOGY, 2006, 66 (02) : 112 - 119
  • [9] QUALITY OF LIFE OF ENTERIC-COATED MYCOPHENOLATE SODIUM (EC-MPS) IN RENAL TRANSPLANT RECIPIENTS WITH GASTROINTESTINAL TRACT COMPLAINTS TO MYCOPHENOLATE MOFETIL (MMF). MYVIDA STUDY
    Andres, I
    Font, B.
    Mora, S.
    Lahoz, R.
    Ortega, F.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A311 - A311
  • [10] Safety assessment of the conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in stable renal transplant recipients
    Massari, P
    Duro-Garcia, V
    Girón, F
    Hernández, E
    Juárez, F
    Castro, C
    Toledo, M
    [J]. TRANSPLANTATION PROCEEDINGS, 2005, 37 (02) : 916 - 919
12345